Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-513159-33-00Phase 4Completed
Phase 4 trial of albumin (human) and ringer's solution (2 arms), sponsored by Region Östergötland. Primary endpoint: Hemoglobin decrease associated with fluid bolus. Started Sep 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-513159-33-00.